论文信息 - TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials Group. - 字舞流文

TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials Group.

F. Cavalli | P. Dombernowsky | S. Gundersen | H. Pinedo | U. Bruntsch | J. Renard | M. V. Van Glabbeke

[1] H. Hansen,et al. A phase I clinical evaluation of 1-(2-chloroethyl)-3-[2-(dimethylaminosulphonyl)ethyl]-1-nitrosou rea (TCNU). , 1987, European journal of cancer & clinical oncology.

[2] J. S. Macpherson,et al. Phase I study of TCNU, a novel nitrosourea. , 1987, European journal of cancer & clinical oncology.

[3] M. Slavik,et al. Clinical comparison of the nitrosoureas , 1975, Cancer.

[4] R. Wittes,et al. Clinical drug development: an analysis of phase II trials, 1970-1985. , 1987, Cancer treatment reports.